Post Market Evaluation of Real World Outcomes and Durability to Support Implantable Inceptiv™ Spinal Cord Stimulation Therapy

← catalyst calendar

NCT07507422 · readout in 1,043 d

Sponsored by Medtronic (industry) · MDT — their whole pipeline →.

Phase

—

Status

Recruiting

Study type

Observational

Enrollment

970estimated

Sites

Country

United States

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis

Date

Filed

Basis

What it is

Start

2026-04-17

actual

When the study began enrolling

Primary completion

2029-06-27

estimated

The date the last participant is measured for the primary outcome — the readout window

Study completion

2034-01-11

estimated

The whole study's end, after follow-up

First posted

2026-04-02

actual

When this record first appeared on the registry

Results posted

—

When the sponsor posted results to the registry

Record updated

2026-05-04

actual

The sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Conditions

Chronic Pain
Intractable Pain

Intervention

Device: Commercially available Inceptiv™ neurostimulation systems

Primary outcomes

what the primary-completion date above is the date OF

Percentage of implanted patients who have a ≥ 50% improvement in pain score as assessed by numeric pain rating scale (NPRS) from baseline for the predominant pain being treated at 6 months following device activation

measured Baseline and 6 months after device activation

Percentage of implanted patients who are a composite responder at 6 months following device activation

measured Baseline and 6 months after device activation

Permalink · MDT's whole pipeline · Catalyst calendar · Every registered study · What changed